Real-World Outcomes of Abemaciclib Dose-Escalation Strategy in High-Risk Early Breast Cancer. Lad N, Blocker S, Monson T, Grauer D, et al. Clin Breast Cancer 2026;26:57-62.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lad N, Blocker S, Monson T, Grauer D, et al. Real-World Outcomes of Abemaciclib Dose-Escalation Strategy in High-Risk Early Breast Cancer. Clin Breast Cancer 2026;26:57-62.
PMID: 41946130